Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Public ClinicalTrials.gov record NCT01624480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to evaluate the pharmacokinetics, pharmacodynamics, and safety of single and multiple doses of armodafinil (50, 100, and 150 mg/day) in children and adolescents with excessive sleepiness associated with narcolepsy.
Study identification
- NCT ID
- NCT01624480
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2012 (Type not available)
- Primary completion
- Sep 2015 (Actual)
- Completion
- Dec 2015 (Actual)
- Last update posted
- Nov 9, 2021
2012 – 2015
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 12 | Birmingham | Alabama | — | — |
| Teva Investigational Site 17 | Birmingham | Alabama | — | — |
| Teva Investigational Site 7 | Little Rock | Arkansas | — | — |
| Teva Investigational Site 18 | Orange | California | — | — |
| Teva Investigational Site 16 | San Diego | California | — | — |
| Teva Investigational Site 4 | Stanford | California | — | — |
| Teva Investigational Site 9 | Clearwater | Florida | — | — |
| Teva Investigational Site 26 | Miami Lakes | Florida | — | — |
| Teva Investigational Site 5 | Spring Hill | Florida | — | — |
| Teva Investigational Site 25 | Winter Park | Florida | — | — |
| Teva Investigational Site 1 | Atlanta | Georgia | — | — |
| Teva Investigational Site 2 | Atlanta | Georgia | — | — |
| Teva Investigational Site 20 | Louisville | Kentucky | — | — |
| Teva Investigational Site 15 | Grand Blanc | Michigan | — | — |
| Teva Investigational Site 3 | West Seneca | New York | — | — |
| Teva Investigational Site 23 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 10 | Toledo | Ohio | — | — |
| Teva Investigational Site 13 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 19 | West Chester | Pennsylvania | — | — |
| Teva Investigational Site 8 | Houston | Texas | — | — |
| Teva Investigational Site 14 | San Antonio | Texas | — | — |
| Teva Investigational Site 27 | Everett | Washington | — | — |
| Teva Investigational Site 24 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01624480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01624480 live on ClinicalTrials.gov.